^EN This looks less like generosity and more like political insurance — a hedge against antitrust and safety crackdowns as Washington tightens its grip on frontier AI labs. Watch whether other major AI firms feel pressured to follow suit.

^EN The gray market for weight-loss drugs is outrunning regulation — people are self-administering compounds still in clinical trials, chasing results Big Pharma hasn't even approved yet. Expect a crackdown on underground suppliers before summer ends.

^EN Glass-core substrates are the packaging bottleneck everyone's racing to solve for next-gen AI chips — Samsung locking in a Japanese materials partner signals it doesn't want to be caught flat-footed against Intel and Absolics.

^EN K-beauty's growth engine was cheap, direct-to-consumer shipping — that edge just got taxed away in two of its biggest markets. Brands that can't pivot from 'cheap and small' to 'customer experience' will get squeezed hard this year.

^EN This is a rare bright spot in a PC market being squeezed by soaring memory prices — Dell's enterprise relationships gave it pricing power that consumer-focused rivals didn't have.

^EN A disclosure system nobody uses isn't a disclosure system — it's a fig leaf. Without mandatory participation or real penalties, the firms with the worst security posture have every incentive to simply opt out.

^EN Telecom equipment makers have watched AI reshape every other layer of tech and are now racing to avoid becoming commodity pipes — partnering with Nvidia is as much a branding move as a technical one.

^EN The gap has shrunk from earlier rounds but is still wide enough that this will likely go to the wire — or to the minimum wage commission's public-interest members casting the deciding vote, as usual.

^EN Regional tours this early are less about policy than about locking down delegate blocs — a sign the race is expected to be tight enough that ground game will matter more than name recognition.

^EN Copilot keeps turning into a model marketplace rather than a single-vendor product — good for developers who can now pick the best coder for the job, but it also means Chinese labs like Moonshot are now competing directly inside Microsoft's own toolchain.

^EN The irony of malware riding through the platform holder's own distribution pipe is the real story — it's a reminder that app-store review processes catch known signatures, not novel behavior, and that gap is exactly where attackers live.